My team has been working on establishing gene-based diagnostics for rare forms of diabetes. This article in New Yorker reminds us of the importance of genetic medicine and gene-based diagnostics.
We clearly need new and innovative therapeutics for each genetic disorder. To accomplish this, we need new diagnostics to figure out what’s really going on in each patient. The medicine has changed dramatically in the past 5 years due to the development of next generation gene sequencing, gene editing, and stem cell-based therapeutics. We should bring these innovative diagnostics and therapeutics to out patients swiftly. We need to raise awareness of these.
Thank you for reading this blog. It is a beautiful day here in St. Louis. I hope you have a wonderful Sunday. Cordially, Fumi Urano